Jagsonpal Pharmaceuticals standalone net profit declines 49.17% in the December 2023 quarter

Sales decline 21.43% to Rs 47.25 crore

Net profit of Jagsonpal Pharmaceuticals declined 49.17% to Rs 3.96 crore in the quarter ended December 2023 as against Rs 7.79 crore during the previous quarter ended December 2022. Sales declined 21.43% to Rs 47.25 crore in the quarter ended December 2023 as against Rs 60.14 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales47.2560.14 -21 OPM %7.1714.37 -PBDT5.6810.20 -44 PBT5.279.87 -47 NP3.967.79 -49

Powered by Capital Market - Live News